“pancreatic-cancer” Archives

in
Entry Author Date Location
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Safety Issue Triggers Partial FDA Hold for Aduro Bio 10/24/16 San Francisco
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Still Stuck Below IPO Price, Merrimack Restructures, CEO Resigns 10/03/16 Boston
Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound 05/16/16 San Francisco
Texas Roundup: Rapamycin, SparkCognition, MolecularMatch, Rackspace 04/27/16 Texas
A New Coat Makes The Difference in Rapamycin’s Disease Prevention 04/26/16 Texas
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Houston’s Fannin Forms Company to Fight Inflammation-Induced Cancers 09/21/15 Texas
Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers 06/30/15 Wisconsin
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment 08/27/14 Texas
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
West Coast Biotech Roundup: NanoString, Sequenom/Agena, CIRM, & More 06/06/14 San Diego
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3 05/01/14 Boston
Time to Come Clean: Why A High-Tech Guy Envies the Low-Tech World 11/12/13 Seattle
Investors to Get $300M as FDA Approves Celgene Drug For Pancreatic Cancer 09/06/13 New York
Celgene Drug Keeps Pancreatic Patients Alive an Extra Two Months in Trial 01/23/13 New York
San Diego Life Sciences Roundup: Amylin Buyout, PDUFA, & More 07/05/12 San Diego
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug 01/20/12 Boston
Repligen Seeks Approval for Imaging Product While Pursuing Rare-Disease Drugs and Manufacturing Platform 09/01/11 Boston
Page 1 of 2 next page »